NCT05423652Active, not recruiting
Aiding COPD and CHF Ultrasound-guided Management Through ENhanced Point Of Care UltraSound
Source: ClinicalTrials.gov · Last updated 2 Apr 2025
Brief summary (registry, in English)
Single-center, two-arm, parallel, randomized controlled trial comparing enhanced daily assessments for patients with COPD and/or CHF using point of care ultrasound with PRESUNA software (POCUS-PRESUNA) versus standard care provided by home-based acute care through a tertiary acute care medical teaching hospital. The objectives are to evaluate POCUS-PRESUNA on improving patient experience, provider experience, improve healthcare utilization/costs, and to test the feasibility of incorporating longitudinal POCUS assessments in home-based acute care via remotely acquired images by non-physicians.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 20 (actual)
- First submitted
- 5 May 2022
- Start date
- 16 Oct 2023
- Primary completion date
- 31 Mar 2025
- Lead sponsor
- Michelle Grinman
- Diseases
- COPD
- NCT number
- NCT05423652
What you commit to
- Study type: Interventional
- Participants enrolled: 20
- From 16 Oct 2023 to the primary completion date, 31 Mar 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Criteria the registry did not label
- Patient Inclusion Criteria:
- 18 years of age or older
- Has a provincial health care number
- Functionally safe to receive HH care or have sufficient caregiving to support them at home
- Stable enough to be cared for at home - stable vital signs and requiring no more than 2 visits per day
- Able and willing to follow a management plan
- Provides consent to receive care on HH
- Diagnosis of CHF and/or COPD that requires HH care
- No painful/broken ribs that could be affected by pressure applied when performing lung POCUS
- Patient Exclusion Criteria:
- Not eligible for HH care
- New unstable rib fractures
- Prior history of allergy to ultrasound gel
- Participant refusal to participate in research study
- Provider inclusion criteria
- Attending clinician on the home hospital program within the next 3-6 months
- Provides informed consent to participate in the study, including necessary training for the use of POCUS and/or PRESUNA
- Provider exclusion criteria
- Not a home hospital clinician
- Refuses to consent for the study / training.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Rockyview General Hospital Coordinator of this site? Confirm its status | Calgary | Canada | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.